The Centers for Medicare & Medicaid Services is pushing back the deadline to participate in the Trump administration’s new bundled payment program, and Vermont is planning to regulate the White House’s recently announced associated health plans.
Mark Linthicum, director of scientific communications at IVI, discusses the problems with measuring the “value” in value-based payment arrangements. He also has some recommendations for CMS.
Congress and the Trump administration are planning speeches and hearings involving the 340B program next week, and it looks like an overhaul of the drug discount program might be on the horizon.
The future of Medicaid in Nebraska appears to be in voters’ hands, as advocates claim to have collected enough signatures to put Medicaid expansion on the November ballot.
While the government and insurers are taking steps to curb opioid prescriptions and enhance treatments, nonmedication pain management needs to be pumped up as well to stop the problem at its core, executives at Amercian Specialty Health told FierceHeal…
About 1.1 million people have already dropped from their exchange plan in 2018. While that decline is lower than it was in 2017, signaling greater stabilization, policy changes are likely to disrupt the marketplace next year.
Under a demonstration project, CMS will move ahead with plans to test whether certain Medicare Advantage plans should qualify as an advanced alternative payment model and exempt doctors from MIPS.
Another high-profile insurance merger is complete, and Kentucky’s governor is already slashing the state’s Medicaid program following his courtroom loss over work requirements.
The Centers for Medicare and Medicaid Services released new data in its Open Payments database last week. The information, meant to create transparency about the relationships between doctors and teaching hospitals with drug companies, provides informa…
Pharmacy staff and physicians at hospitals across the U.S. are still grappling with an opioid crisis based on shortages, rather than overuse and abuse, while they await potential relief from federal agencies.